These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15194633)

  • 1. Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?
    Taché Y
    Gut; 2004 Jul; 53(7):919-21. PubMed ID: 15194633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of corticotropin releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
    Taché Y; Martinez V; Million M; Maillot C
    Eur J Surg Suppl; 2002; (587):16-22. PubMed ID: 16144197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome.
    Labus JS; Hubbard CS; Bueller J; Ebrat B; Tillisch K; Chen M; Stains J; Dukes GE; Kelleher DL; Naliboff BD; Fanselow M; Mayer EA
    Gastroenterology; 2013 Dec; 145(6):1253-61.e1-3. PubMed ID: 23954313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of enteric neurons by interleukin-6 and corticotropin-releasing factor contributes to visceral hypersensitivity and altered colonic motility in a rat model of irritable bowel syndrome.
    Buckley MM; O'Halloran KD; Rae MG; Dinan TG; O'Malley D
    J Physiol; 2014 Dec; 592(23):5235-50. PubMed ID: 25260633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRF1 receptors as a therapeutic target for irritable bowel syndrome.
    Martinez V; Taché Y
    Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats.
    Greenwood-Van Meerveld B; Johnson AC; Cochrane S; Schulkin J; Myers DA
    Neurogastroenterol Motil; 2005 Jun; 17(3):415-22. PubMed ID: 15916629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor receptor 1 (CRF-R1) antagonists: Promising agents to prevent visceral hypersensitivity in irritable bowel syndrome.
    Lv Y; Wen J; Fang Y; Zhang H; Zhang J
    Peptides; 2022 Jan; 147():170705. PubMed ID: 34822913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.
    Nozu T; Okumura T
    J Gastroenterol; 2015 Aug; 50(8):819-30. PubMed ID: 25962711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for corticotropin-releasing factor in functional gastrointestinal disorders.
    Taché Y; Kiank C; Stengel A
    Curr Gastroenterol Rep; 2009 Aug; 11(4):270-7. PubMed ID: 19615302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational agents for the irritable bowel syndrome.
    Ghaith O; El-Halabi M; Hashash JG; Sharara AI
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1161-78. PubMed ID: 20836617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of substituted pyrimidines as corticotropin releasing factor (CRF) receptor ligands.
    Kuppast B; Spyridaki K; Liapakis G; Fahmy H
    Eur J Med Chem; 2014 May; 78():1-9. PubMed ID: 24675175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor type-1 receptor antagonists: the next class of antidepressants?
    Nielsen DM
    Life Sci; 2006 Jan; 78(9):909-19. PubMed ID: 16122764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors.
    Kiank C; Taché Y; Larauche M
    Brain Behav Immun; 2010 Jan; 24(1):41-8. PubMed ID: 19698778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can modulating corticotropin releasing hormone receptors alter visceral sensitivity?
    Fukudo S; Saito K; Sagami Y; Kanazawa M
    Gut; 2006 Feb; 55(2):146-8. PubMed ID: 16407379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders.
    Bravo JA; Dinan TG; Cryan JF
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):666-83. PubMed ID: 20860876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Otilonium Bromide treatment prevents nitrergic functional and morphological changes caused by chronic stress in the distal colon of a rat IBS model.
    Traini C; Idrizaj E; Garella R; Faussone-Pellegrini MS; Baccari MC; Vannucchi MG
    J Cell Mol Med; 2021 Jul; 25(14):6988-7000. PubMed ID: 34109728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule antagonists of the corticotropin releasing factor (CRF) receptor: recent medicinal chemistry developments.
    Tellew JE; Luo Z
    Curr Top Med Chem; 2008; 8(6):506-20. PubMed ID: 18397172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.